Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) shares rose 3.6% during trading on Thursday . The company traded as high as $0.48 and last traded at $0.48. Approximately 28,797 shares changed hands during trading, a decline of 97% from the average daily volume of 930,280 shares. The stock had previously closed at $0.46.
Ainos Stock Up 3.6 %
The stock has a market cap of $6.60 million, a PE ratio of -0.19 and a beta of 1.40. The business has a 50 day moving average of $0.49 and a 200-day moving average of $0.67. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08.
About Ainos
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Featured Articles
- Five stocks we like better than Ainos
- Election Stocks: How Elections Affect the Stock Market
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Why Invest in High-Yield Dividend Stocks?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Fintech Stocks With Good 2021 Prospects
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
